Biliary Stents Market Size to Attain USD 762.42 Million by 2033

Prathamesh

2 months ago

The global biliary stents market size is estimated to hit around USD 762.42 million by 2033 from USD 443.39 million in 2023, at a CAGR of 5.57% from 2024 to 2033.

Biliary Stents Market Size 2024 to 2033

Key Points

North America captured the most significant share of the biliary stents market.
By product type, the metal segment has held the largest market share in 2023.
By application, the gallstone segment has held the largest segment of the biliary stents market.
By end use, the hospital segment held the dominating position in the market in 2023.

The biliary stents market refers to the segment of the medical device industry dedicated to the production and distribution of stents used in the biliary system. Biliary stents are small, flexible tubes placed in the bile duct to treat obstructions or strictures caused by various medical conditions such as gallstones, tumors, or inflammation. These stents serve as a conduit to keep the bile duct open, allowing the passage of bile from the liver to the small intestine, thus relieving symptoms and preventing complications associated with biliary obstruction.

Get a Sample: https://www.precedenceresearch.com/sample/3931

List of Contents

Toggle

Growth Factors

Several factors contribute to the growth of the biliary stents market. Firstly, the increasing incidence of biliary disorders such as gallstones and biliary strictures drives the demand for biliary stents. As the population ages and the prevalence of chronic diseases rises, the number of patients requiring biliary interventions is expected to grow. Additionally, advancements in stent design and technology have led to the development of more efficient and durable stents, enhancing their efficacy and safety profile. Moreover, the growing adoption of minimally invasive procedures, including endoscopic retrograde cholangiopancreatography (ERCP), which often requires the placement of biliary stents, further fuels market growth.

Region Insight

The biliary stents market exhibits a global presence, with significant regional variations in market dynamics. North America and Europe are prominent regions in terms of market share, driven by high healthcare expenditures, well-established healthcare infrastructure, and favorable reimbursement policies. Asia-Pacific is anticipated to witness rapid growth attributed to the increasing prevalence of biliary disorders, rising healthcare expenditure, and expanding access to advanced medical technologies in countries like China, India, and Japan. Latin America and the Middle East & Africa regions are also expected to contribute to market growth, albeit to a lesser extent, owing to improving healthcare infrastructure and rising awareness about minimally invasive procedures.

Biliary Stents Market Scope

Report Coverage	Details
Growth Rate from 2024 to 2033	CAGR of 5.57%
Global Market Size in 2023	USD 443.39 Million
Global Market Size by 2033	USD 762.42 Million
Largest Market	North America
Base Year	2023
Forecast Period	2024 to 2033
Segments Covered	By Type, By Application, and By End-use
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Biliary Stents Market Dynamics

Drivers:

Several drivers propel the growth of the biliary stents market. One of the primary drivers is the rising prevalence of biliary disorders, including gallstones, bile duct tumors, and strictures, driven by factors such as sedentary lifestyles, dietary habits, and increasing age. Additionally, the growing adoption of minimally invasive techniques for biliary interventions, such as ERCP and percutaneous transhepatic cholangiography (PTC), fuels the demand for biliary stents. Moreover, technological advancements in stent design, materials, and delivery systems contribute to improved efficacy, safety, and patient outcomes, further driving market growth.

Restraints:

Despite the favorable market conditions, the biliary stents market faces certain restraints. One significant challenge is the risk of stent-related complications, including stent migration, occlusion, and tissue ingrowth, which can necessitate repeat interventions and compromise patient outcomes. Moreover, the availability of alternative treatment modalities, such as surgical resection and liver transplantation, for certain biliary conditions poses a competitive challenge to the widespread adoption of biliary stents. Additionally, stringent regulatory requirements for medical devices and the high cost associated with advanced stent technologies may impede market growth, particularly in developing regions with limited healthcare resources.

Opportunities:

Despite the challenges, the biliary stents market presents several opportunities for growth and innovation. Expanding indications for biliary stent placement, such as in the management of benign biliary strictures and post-operative complications, broaden the market scope and address unmet clinical needs. Furthermore, the integration of advanced imaging modalities, such as fluoroscopy and intraductal ultrasound, into biliary interventions enhances procedural accuracy and patient outcomes, driving demand for specialized stent designs. Moreover, strategic collaborations between medical device companies and healthcare providers, along with investments in research and development, facilitate the introduction of novel stent technologies and expand market reach, particularly in emerging markets with evolving healthcare infrastructures.

Recent Developments

In January 2024, Olympus concluded the acquisition of Taewoong Medical Co. Ltd., a leading Korean gastrointestinal stent company.
In October 2022, Cordis, a global frontrunner in the innovation and production of interventional cardiovascular and endovascular technologies, revealed its acquisition of MedAlliance, a Switzerland-based firm renowned for pioneering drug-eluting balloons.
In June 2022, Boston Scientific announced its agreement to acquire a majority stake in M.I.Tech Co. Ltd. from Synergy Innovation Co. Ltd.